A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma

Table 4 Comparison of single and parallel detection of CA19-9 and model

Methods	Number of positive	Number of negative	Positive rate
CA19-9	101	26	79.52^a
3-TAAbs Panel	73	54	57.48^b
Panel + CA19-9	118	9	92.91^c

^a: The chi-square test showed P < 0.001 for CA19-9 and 3-TAAbs Panel; ^b: The chi-square test showed P < 0.001 for CA19-9 and Panel + CA19-9; ^c: The chi-square test showed P < 0.001 for 3-TAAbs Panel and Panel + CA19-9.

ISSN: 1475-2867